Latest Cancer News

Promising Survival for AML Patients Treated with Stem Cells from Related Half Matched Donor (07-30-2015)
Patients with acute myeloid leukemia (AML) may have a promising new treatment option. Research shows that stem cell transplant from a “half matched” related donor plus chemotherapy results in similar... Continue Reading

Study of Opdivo® versus Afinitor® Stopped Early when Opdivo Demonstrated Better Survival (07-29-2015)
Patients with advanced or metastatic kidney cancer who are treated with Opdivo® (nivolumab) have better overall survival than those treated with Afinitor® (everolimus), according to findings from a Phase... Continue Reading

Blincyto® in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Appears Promising (07-23-2015)
Biotechnology company Amgen has announced that their immunotherapy drug Blincyto® (blinatumomab) appears promising in the treatment of adults with Philadelphia chromosome-positive (Ph+) acute lymphoblastic... Continue Reading

More Cancer News

Patient Resources

VirtualTour_280x99

CoC Logo 541 ACCREDITED PROGRAM caps